1. Population-based study of long-term survival in patients with clinically localised prostate cancer;Lu-Yao;Lancet,1997
2. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751;Dionne;Clin Can Res,1998
3. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and trk tyrosine kinase inhibitors, CEP-751 or CEP-701;George;Cancer Res,1999
4. The proto-oncogene Bcl-2 and its role in regulating apoptosis;Kroemer;Nature Med,1997
5. Target sites for manipulating apoptosis in prostate cancer;Watson;BJU Int,2000